Preparation and Antioxidant Study of PEG-Modified EGCG/Cur Composite Liposomes

被引：0
|
作者：
Li L. [1 ,2 ]
Yuan C. [1 ,2 ]
Wang M. [1 ,2 ]
Zhu M. [1 ,2 ]
Jin R. [1 ,2 ]
机构：
[1] School of Food and Bioengineering, Hefei University of Technology, Hefei
[2] Engineering Center of Agricultural Products Biochemical Engineering, Ministry of Education, Hefei
来源：
Science and Technology of Food Industry | 2023年 / 44卷 / 09期
关键词：
curcumin; epigallocatechin gallate; liposomes; polyethylene glycol; surface modification;
D O I：
10.13386/j.issn1002-0306.2022060218
中图分类号：
学科分类号：
摘要：
In this study, epigallocatechin gallate (EGCG)/curcumin (Cur) composite liposomes (EGCG/Cur-L) were prepared by thin-film hydrophoresis, and the optimal preparation process was determined by single-factor test. To increase the stability of liposomes, the surface of the composite liposomes was modified with distearoyl phosphatidylethanolaminepolyethylene glycol 2000 (DSPE-PEG2000), and the encapsulation rate, particle size distribution, micromorphology, and modification effect of both liposomes were investigated, and the oxidative stability of liposomes was evaluated by DPPH method. The results showed that the optimal process for the composite liposomes was: Lecithin to cholesterol mass ratio of 6:1, PBS buffer solution pH of 6.5, EGCG added amount 6 mg, Cur added amount 3 mg, and hydration temperature of 55 ℃. The encapsulation rate of EGCG was 68.78%, the encapsulation rate of Cur was 90.23%, the average particle size was 183.8±5.4 nm, the polydispersity coefficient (PDI) was 0.178±0.01, and the average Zeta-potential was −34.7±0.62 mV. The encapsulation rate of EGCG after modification was 60.31%, and the encapsulation rate of Cur was 88.53%. After surface modification, the encapsulation rate of Cur did not change significantly, and the encapsulation rate of EGCG decreased, dynamic light scattering (DLS) and transmission electron microscopy (TEM) results showed that the average particle size of the modified liposomes increased from the unmodified 183.8 nm to 374.5 nm, Zeta-potential and Fourier infrared analysis indicated that DSPE-PEG2000 was successfully modified on the liposome surface and did not change the internal structure of the liposomes. The modified liposomes had the highest DPPH scavenging rate and all had greater oxidative stability than other liposomes within 15 days, indicating that DSPE-PEG2000 could enhance the antioxidant capacity of liposomes. © Science and Technology of Food Industry 2023.
引用
收藏
页码：88 / 95
页数：7
相关论文
共 41 条
  • [1] GAN R Y, LI H B, SUI Z Q, Et al., Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review[J], Crit Rev Food Sci Nutr, 58, (2018)
  • [2] HAYKAWA S, SAITO K, MIYOSHI N, Et al., Anti-cancer effects of green tea by either anti-or pro-oxidative mechanisms[J], Asian Pacific Journal of Cancer Prevention, 17, pp. 1649-1654, (2016)
  • [3] SAHADEVAN R, SINGH S, BINOY A, Et al., Chemico-biological aspects of (-)-epigallocatechin-3-gallate (EGCG) to improve its stability, bioavailability and membrane permeability: Current status and future prospects[J], Critical Reviews in Food Science and Nutrition, pp. 1-30, (2022)
  • [4] RU W Y, JIN C H, KANG Y G, Et al., In vitro study on anti-inflammatory effects of epigallocatechin-3-gallate-loaded nano-and microscale particles[J], International Journal of Nanomedicine, 12, pp. 7007-7013, (2017)
  • [5] BIMONTE S, CASCELLA M, BARBIERI A, Et al., Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: An update of the current state of knowledge[J], Infectious Agents and Cancer, 15, (2020)
  • [6] ALMATROODI S A, ALMATROUDI A, KHAN A A, Et al., Potential therapeutic targets of epigallocatechin gallate (EGCG), the most abundant catechin in green tea, and its role in the therapy of various types of cancer[J], Molecules, 25, (2020)
  • [7] DAI W, RUAN C, ZHANG Y, Et al., Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review[J], Journal of Functional Foods, 65, (2020)
  • [8] SMITH A J, KAVURU P, ARORA K K, Et al., Crystal engineering of green tea epigallocatechin-3-gallate (EGCG) cocrystals and pharmacokinetic modulation in rats[J], Molecular Pharmaceutics, 10, 8, pp. 2948-2961, (2013)
  • [9] HOSSEINI A, HOSSEINZADEH H., Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review[J], Biomed Pharmacother, 99, (2018)
  • [10] EGAN M E, PEARSON M, WEINER S A, Et al., Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects[J], Science, 304, pp. 600-602, (2004)
12345